X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 11c

May 12, 2022 6:10 AM EDT

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

... More